Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Ashwani Gujral of ashwanigujral.com, one can sell Teh Mahindra and add Cera Sanitaryware and Symphony to the portfolio.
Pankaj Pandey of ICICIdirect is of the view that Symphony may test Rs 2745.
Mayuresh Joshi of Angel Broking is of the view that Symphony may move by 15-20 percent.
SP Tulsian of SPTulsian.com is of the view that one may prefer Symphony.
Prakash Diwan of prakashdiwan.in is of the view that one can buy Symphony.
According to Meghana V Malkan of malkansview.com, one may buy Symphony with a target of Rs 2800.
Dipan Mehta - Member at BSE & NSE is of the view that one may look at Symphony.
Dipan Mehta, Member at BSE & NSE is of the view that one may look at pharma stocks with a long term view.
Amit Harchekar of A Plus Analytics recommends buying Symphony on declines.
Here are top 10 stocks to focus on January 19 - Reliance Industries, IOC, Axis Bank, Prestige Estates, Wipro, M&M Financials, Oberoi Realty, Symphony, V-Guard and Sesa Sterlite.
According to Vinay Khattar, Associate Director & Head of Research at Edelweiss Financial Services, Symphony is still a very interesting bet.
Symphony can test Rs 1500 in six months time, says SP Tulsian, sptulsian.com.